Back to top
more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$606.45 USD

606.45
815,582

+8.42 (1.41%)

Updated Aug 6, 2024 03:46 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (99 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Boston Scientific, Farapulse Sign Deal for Treatment of AF

Boston Scientific (BSX) aims to provide a comprehensive portfolio of electrophysiology products and services via the latest investment agreement.

Abbott's MitraClip G4 Receives CE Mark for Treatment of MR

Abbott's (ABT) MitraClip G4 is expected to improve MR patients' quality of life post its usage eligibility in Europe and other countries recognizing the CE Mark.

LabCorp Boosts Oncology Offerings With Resolution ctDx Launch

This development comes on the heels of LabCorp's (LH) commercial partnership with non-invasive liquid biopsy platform developer, Resolution Bioscience.

Baxter's Clinimix and Clinimix E Injections Receive FDA Nod

Baxter's (BAX) Clinimix and Clinimix E with Higher Protein Injection received FDA approval, which will help clinicians to improve care for critically ill patients.

Quest Diagnostics New Tests Uptake Strong Amid Coronavirus Woe

Heavy demand for COVID-19 molecular testing helps partially offset the base volume decline for Quest Diagnostics (DGX).

Medtronic TYRX Driveline Gets FDA's Breakthrough Designation

This development helps Medtronic (MDT) to augment its research work in the space of interventional and surgical treatment of cardiovascular disease and cardiac arrhythmias.

Here's Why You Should Hold on to ResMed (RMD) Stock for Now

Investors continue to be positive about ResMed (RMD) owing to its robust product line and consistent high demand for its critical care products.

Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know

Thermo Fisher Scientific (TMO) closed the most recent trading day at $430.24, moving +1.12% from the previous trading session.

Here's Why You Should Avoid Betting on Intuitive Surgical Now

Intense competition in the global MedTech space and weak operational performance weighs on Intuitive Surgical (ISRG).

Veeva's Offering Chosen by Idorsia to Drive Digital Engagement

Veeva Systems' (VEEV) Commercial Cloud selected by Idorsia to enhance its digital field force in the United States, Japan and countries across Europe.

The Zacks Analyst Blog Highlights: MDRX, VEEV, DGX, TMO and ZM

The Zacks Analyst Blog Highlights: MDRX, VEEV, DGX, TMO and ZM

The Zacks Analyst Blog Highlights: FMS, HOLX and TMO

The Zacks Analyst Blog Highlights: FMS, HOLX and TMO

Insulet's Omnipod DASH Shines, New Omnipod Uptake Slows Down

Insulet (PODD) adds significant capacity in preparation of the Omnipod 5 launch in 2021.

Abbott Launches Sports Biosensor in Europe, Boosts CGM Wing

Abbott (ABT) makes its first non-exclusive collaboration with Atlanta-based sports technology company, Supersapiens.

STERIS (STE) Hits a New 52-Week High: What's Driving It?

STERIS (STE) is optimistic about maintaining growth momentum on broader product and service portfolio along with strength in its Life Sciences business.

Medtronic's (MDT) TYRX Envelope Study Results Encouraging

Medtronic's (MDT) TYRX Envelope lowers infection risks and is cost-effective.

PRA Health (PRAH) Enters Into Strategic Deal With Deep Lens

PRA Health's (PRAH) deal with Deep Lens can help detect and match oncology patients to suitable clinical trials and best precision therapies.

Here's Why You Should Retain Cooper Companies (COO) Stock

Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

Urmimala Biswas headshot

Is Another Great Depression Imminent or Is it Just a Myth?

Asian countries have already shown clear signs of major economic recession.

Trina Mukherjee headshot

3 MedTech Outperformers to Grab Amid September Pullback

Let's grab these three stocks that have continued to show tremendous promise despite market volatility resulting from the coronavirus pandemic.

QIAGEN (QGEN) Completes Buyout of NeuMoDx, Expands Portfolio

QIAGEN (QGEN) expands portfolio of automated testing solutions to address laboratory needs in almost any setting for molecular diagnostics via the completed buyout of NeuMoDx.

Thermo Fisher Expands Lab Plastic Making for Coronavirus Support

Thermo Fisher (TMO) consumables already support critical COVID-19 work and include sample collection vials and lab essentials.

Thermo Fisher Scientific (TMO) Stock Moves -0.28%: What You Should Know

Thermo Fisher Scientific (TMO) closed at $433.88 in the latest trading session, marking a -0.28% move from the prior day.

Bruker's Buyout of Canopy Biosciences Enhances Portfolio

Bruker (BRKR) expands its multi-dimensional immune profiling by adding ChipCytometry tools via the acquisition of Canopy Biosciences.

Here's Why You Should Retain McKesson (MCK) Stock for Now

McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.